Navigation Links
Loyola receives NIH grant to study vitamin D deficiency in African populations
Date:11/30/2011

MAYWOOD, Ill. Researchers at Loyola University Chicago Stritch School of Medicine have received a five-year, $2.8 million grant from the National Institutes of Health to study vitamin D deficiency in people of African descent.

Researchers will evaluate the relation between low vitamin D levels and risks for certain chronic diseases, including osteoporosis and heart disease.

Evidence from numerous previous studies is "inconclusive and needs to be studied further," said Ramon Durazo, PhD, principal investigator and assistant professor in the Department of Preventive Medicine and Epidemiology. "This grant will allow us to take a more in-depth look at the role this nutrient plays in a specific group of people who are at risk for these conditions."

The study will include about 2,500 people, ages 25-45, from Ghana, South Africa, Seychelles, Jamaica and metropolitan Chicago. Researchers will determine whether lower vitamin D levels in African and African-descent populations compared with whites should be considered abnormal, or whether this disparity represents an ethnic-specific trait. The study also will evaluate whether vitamin D deficiency is related to bone density and factors that contribute to heart disease, including obesity, high blood pressure and blood sugar levels.

In the United States, African-Americans have been reported to have much lower vitamin D levels. "This is currently thought to be due to their darker skin color, which impairs the ability to utilize the sun for the production of the nutrient," said Pauline Camacho, MD, director of Loyola University Health System's Osteoporosis and Metabolic Bone Disease Center. "Also, this group often has a higher body mass index. This could play a role in the deficiency, as vitamin D is a fat-soluble vitamin."

Only about 3 percent of African-Americans have optimal levels of vitamin D. Some researchers believe low levels may contribute to obesity, high blood pressure and cardiovascular disease.

Sampling African-origin populations across a range of latitudes, calcium intakes, diet patterns and lifestyles will enable researchers to help define the optimal level of vitamin D in the multi-ethnic U.S. population.


'/>"/>
Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Related biology news :

1. Wistar Institute researcher receives New Innovator award from NIH
2. L-1 Identity Solutions Receives $5.9 Million Drivers License Contract Expansion from the State of Mississippi
3. Kount Receives Patent for Device Fingerprinting
4. American College of Medical Genetics receives $13.5M NIH contract
5. Penn State receives new NASA astrobiology grant
6. Global Viral Forecasting Initiative receives $11M to implement pandemic early warning system
7. Vidaza receives positve opinion from European CHMP
8. Case Western Reserve receives Ellison Medical Foundation New Scholar in Aging award
9. Montana State partnership receives $66.9M for carbon sequestration
10. Oklahoma EPSCoR receives $20 million for biofuels research
11. UC Riverside rice geneticist receives high honor from US Department of Agriculture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... -- Michael Johnson, co-founder of Visikol Inc. a company originally funded with ... to the elite "Forbes 30 Under 30" list in the Science ... 20 fields nationwide to be recognized as a leader in business ... ... a PhD candidate at Rutgers University. Visikol ...
(Date:1/4/2017)... thousands of attendees at this year,s International Consumer Electronics Show (CES), ... devices and services, will be featuring its new line of ULTRA CONNECT ... special CES Exhibit Suite , the new upper arm and wrist smart ... product platform.  Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... ... ... Back pain relief technology is now available without a prescription at What ... relief for WAR members. , This spinal restoration platform boasts utilization of technology that ... suffering from chronic back pain. , What A Relief Back Pain Centers ...
(Date:1/11/2017)... , PITTSBURGH and BENGALURU, ... (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, ... Drug Administration (FDA) has accepted Mylan,s biologics license application ... through the 351(k) pathway. This product is a proposed ... certain HER2-positive breast cancers. The anticipated FDA goal date ...
(Date:1/11/2017)... , Jan. 11, 2017  GenVec, Inc. ... delivery company, announced today that its chief scientific ... a talk entitled  "AdenoVerse™ platform for translational development ... Biotech Showcase at the upcoming Phacilitate Cell & ... Miami , Florida.  Dr. Brough,s presentation will ...
(Date:1/11/2017)... (PRWEB) , ... January 11, 2017 , ... ... signed a multi-year license agreement with Poseida Therapeutics Inc, the San Diego based ... genetic data. Poseida Therapeutics selected KBioBox in order to harness KBioBox’s powerful BioEngine ...
Breaking Biology Technology: